{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T09:52:50Z","timestamp":1792403570898,"version":"4.4.0"},"reference-count":126,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,27]],"date-time":"2024-02-27T00:00:00Z","timestamp":1708992000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004587","name":"Carlos III Health Institute","doi-asserted-by":"publisher","award":["CM22\/00276"],"award-info":[{"award-number":["CM22\/00276"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Carlos III Health Institute","doi-asserted-by":"publisher","award":["CP20\/00003"],"award-info":[{"award-number":["CP20\/00003"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Carlos III Health Institute","doi-asserted-by":"publisher","award":["PI22\/00297"],"award-info":[{"award-number":["PI22\/00297"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003329","name":"Ministerio de Econom\u00eda y Competitividad","doi-asserted-by":"publisher","award":["RTI2019-096724-B-C21"],"award-info":[{"award-number":["RTI2019-096724-B-C21"]}],"id":[{"id":"10.13039\/501100003329","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","award":["SGR 2021 01507"],"award-info":[{"award-number":["SGR 2021 01507"]}],"id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003030","name":"AGAUR","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003030","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003359","name":"Generalitat Valenciana","doi-asserted-by":"publisher","award":["PROMETEO\/2021\/059"],"award-info":[{"award-number":["PROMETEO\/2021\/059"]}],"id":[{"id":"10.13039\/501100003359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003359","name":"Generalitat Valenciana","doi-asserted-by":"publisher","award":["2022 INV-1 00,001"],"award-info":[{"award-number":["2022 INV-1 00,001"]}],"id":[{"id":"10.13039\/501100003359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004837","name":"Ministerio de Ciencia e Innovaci\u00f3n","doi-asserted-by":"publisher","award":["PID2019-10455GB-I00"],"award-info":[{"award-number":["PID2019-10455GB-I00"]}],"id":[{"id":"10.13039\/501100004837","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010198","name":"Government of Spain Ministry of Economy and Competitiveness","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010198","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014440","name":"Espana Ministerio de Ciencia e Innovacion","doi-asserted-by":"publisher","award":["PID2022-141955OB-I00"],"award-info":[{"award-number":["PID2022-141955OB-I00"]}],"id":[{"id":"10.13039\/100014440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014440","name":"Espana Ministerio de Ciencia e Innovacion","doi-asserted-by":"publisher","award":["PID2019-104055GB-I00"],"award-info":[{"award-number":["PID2019-104055GB-I00"]}],"id":[{"id":"10.13039\/100014440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003330","name":"Secretar\u00eda de Estado de Investigacion, Desarrollo e Innovacion","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003330","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002809","name":"Generalitat de Catalunya","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Phytomedicine"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.phymed.2024.155493","type":"journal-article","created":{"date-parts":[[2024,3,6]],"date-time":"2024-03-06T03:15:28Z","timestamp":1709694928000},"page":"155493","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Silibinin is a suppressor of the metastasis-promoting transcription factor ID3"],"prefix":"10.1016","volume":"128","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8980-0423","authenticated-orcid":false,"given":"Sara","family":"Verdura","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Antonio","family":"Encinar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexei","family":"Gratchev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c0ngela","family":"Llop-Hern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9515-3285","authenticated-orcid":false,"given":"J\u00falia","family":"L\u00f3pez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eila","family":"Serrano-Herv\u00e1s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6795-3218","authenticated-orcid":false,"given":"Eduard","family":"Teixidor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugeni","family":"L\u00f3pez-Bonet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bego\u00f1a","family":"Martin-Castillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8089-0696","authenticated-orcid":false,"given":"Vicente","family":"Micol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0893-7821","authenticated-orcid":false,"given":"Joaquim","family":"Bosch-Barrera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabet","family":"Cuy\u00e0s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8733-4561","authenticated-orcid":false,"given":"Javier A.","family":"Menendez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.phymed.2024.155493_bib0001","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0132221","article-title":"Uncovering molecular bases underlying bone morphogenetic protein receptor inhibitor selectivity","volume":"10","author":"Alsamarah","year":"2015","journal-title":"PLoS ONE"},{"key":"10.1016\/j.phymed.2024.155493_bib0002","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.ccr.2010.10.023","article-title":"TGF-\u03b2 receptor inhibitors target the CD44(high)\/Id1(high) glioma-initiating cell population in human glioblastoma","volume":"18","author":"Anido","year":"2010","journal-title":"Cancer Cell"},{"key":"10.1016\/j.phymed.2024.155493_bib0003","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1016\/j.cell.2017.08.015","article-title":"Combinatorial signal perception in the BMP pathway","volume":"170","author":"Antebi","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.phymed.2024.155493_bib0004","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1161\/ATVBAHA.118.310760","article-title":"ALK1 loss results in vascular hyperplasia in mice and humans through PI3K Activation","volume":"38","author":"Alsina-Sanch\u00eds","year":"2018","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.phymed.2024.155493_bib0005","doi-asserted-by":"crossref","first-page":"3169","DOI":"10.3390\/cancers12113169","article-title":"Id1 and PD-1 combined blockade impairs tumor growth and survival of KRAS-mutant lung cancer by stimulating PD-L1 expression and tumor infiltrating CD8+ T Cells","volume":"12","author":"Baraibar","year":"2020","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.phymed.2024.155493_bib0006","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S1050-1738(01)00117-7","article-title":"Role of Id proteins in embryonic and tumor angiogenesis","volume":"11","author":"Benezra","year":"2001","journal-title":"Trends Cardiovasc. Med."},{"key":"10.1016\/j.phymed.2024.155493_bib0007","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.jmb.2004.08.043","article-title":"Ubiquitin-dependent degradation of Id1 and Id3 is mediated by the COP9 signalosome","volume":"343","author":"Berse","year":"2004","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.phymed.2024.155493_bib0008","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s10456-018-9642-5","article-title":"Activin receptor-like kinase 1 is associated with immune cell infiltration and regulates CLEC14A transcription in cancer","volume":"22","author":"Bocci","year":"2019","journal-title":"Angiogenesis"},{"key":"10.1016\/j.phymed.2024.155493_bib0009","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.ctrv.2015.04.008","article-title":"Silibinin and STAT3: a natural way of targeting transcription factors for cancer therapy","volume":"41","author":"Bosch-Barrera","year":"2015","journal-title":"Cancer Treat. Rev."},{"key":"10.1016\/j.phymed.2024.155493_bib0010","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.ctrv.2017.06.003","article-title":"Targeting STAT3 with silibinin to improve cancer therapeutics","volume":"58","author":"Bosch-Barrera","year":"2017","journal-title":"Cancer Treat. Rev."},{"key":"10.1016\/j.phymed.2024.155493_bib0011","doi-asserted-by":"crossref","first-page":"32006","DOI":"10.18632\/oncotarget.7900","article-title":"Response of brain metastasis from lung cancer patients to an oral nutraceutical product containing silibinin","author":"Bosch-Barrera","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.phymed.2024.155493_bib0012","doi-asserted-by":"crossref","first-page":"4168","DOI":"10.3390\/cancers13164168","article-title":"Silibinin suppresses tumor cell-intrinsic resistance to nintedanib and enhances its clinical activity in lung cancer","volume":"13","author":"Bosch-Barrera","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.phymed.2024.155493_bib0013","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1158\/1078-0432.CCR-12-1558","article-title":"An epithelial-mesenchymal transition gene signature predicts resistance to EGFR and PI3K inhibitors and identifies Axl as a therapeutic target for overcoming EGFR inhibitor resistance","volume":"19","author":"Byers","year":"2013","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.phymed.2024.155493_bib0014","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1479-5876-11-13","article-title":"Id1 and Id3 co-expression correlates with clinical outcome in stage III-N2 non-small cell lung cancer patients treated with definitive chemoradiotherapy","volume":"11","author":"Casta\u00f1on","year":"2013","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.phymed.2024.155493_bib0015","doi-asserted-by":"crossref","first-page":"2918","DOI":"10.1038\/s41598-018-21061-1","article-title":"Epithelial-mesenchymal transition (EMT) signature is inversely associated with T-cell infiltration in non-small cell lung cancer (NSCLC)","volume":"8","author":"Chae","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.phymed.2024.155493_bib0016","doi-asserted-by":"crossref","first-page":"18351","DOI":"10.1038\/s41598-019-54830-7","article-title":"Structural consequences of BMPR2 kinase domain mutations causing pulmonary arterial hypertension","volume":"9","author":"Chaikuad","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.phymed.2024.155493_bib0017","doi-asserted-by":"crossref","first-page":"5772","DOI":"10.1038\/sj.onc.1210386","article-title":"Id3 is a novel regulator of p27kip1 mRNA in early G1 phase and is required for cell-cycle progression","volume":"26","author":"Chassot","year":"2007","journal-title":"Oncogene"},{"key":"10.1016\/j.phymed.2024.155493_bib0018","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1210\/endo.142.5.8134","article-title":"Hormonal regulation and differential actions of the helix-loop-helix transcriptional inhibitors of differentiation (Id1, Id2, Id3, and Id4) in Sertoli cells","volume":"142","author":"Chaudhary","year":"2001","journal-title":"Endocrinology"},{"key":"10.1016\/j.phymed.2024.155493_bib0019","doi-asserted-by":"crossref","first-page":"2203","DOI":"10.1002\/1878-0261.12963","article-title":"BMP9-ID1 signaling promotes EpCAM-positive cancer stem cell properties in hepatocellular carcinoma","volume":"15","author":"Chen","year":"2021","journal-title":"Mol. Oncol."},{"key":"10.1016\/j.phymed.2024.155493_bib0020","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1007\/s00441-021-03490-z","article-title":"Id proteins: emerging roles in CNS disease and targets for modifying neural stem cell behavior","volume":"387","author":"Chu","year":"2022","journal-title":"Cell Tissue Res."},{"key":"10.1016\/j.phymed.2024.155493_bib0021","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.fct.2013.07.063","article-title":"Silibinin meglumine, a water-soluble form of milk thistle silymarin, is an orally active anti-cancer agent that impedes the epithelial-to-mesenchymal transition (EMT) in EGFR-mutant non-small-cell lung carcinoma cells","volume":"60","author":"Cuf\u00ed","year":"2013","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.phymed.2024.155493_bib0022","doi-asserted-by":"crossref","first-page":"2459","DOI":"10.1038\/srep02459","article-title":"Silibinin suppresses EMT-driven erlotinib resistance by reversing the high miR-21\/low miR-200c signature in vivo","volume":"3","author":"Cuf\u00ed","year":"2013","journal-title":"Sci. Rep."},{"key":"10.1016\/j.phymed.2024.155493_bib0023","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.1158\/0008-5472.CAN-14-3706","article-title":"Endothelial ALK1 is a therapeutic target to block metastatic dissemination of breast cancer","volume":"75","author":"Cunha","year":"2015","journal-title":"Cancer Res."},{"key":"10.1016\/j.phymed.2024.155493_bib0024","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1084\/jem.20091309","article-title":"Genetic and pharmacological targeting of activin receptor-like kinase 1 impairs tumor growth and angiogenesis","volume":"207","author":"Cunha","year":"2010","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.phymed.2024.155493_bib0025","doi-asserted-by":"crossref","first-page":"6999","DOI":"10.1182\/blood-2011-01-330142","article-title":"ALK1 as an emerging target for antiangiogenic therapy of cancer","volume":"117","author":"Cunha","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.phymed.2024.155493_bib0026","doi-asserted-by":"crossref","DOI":"10.1016\/j.fct.2019.110645","article-title":"Revisiting silibinin as a novobiocin-like Hsp90 C-terminal inhibitor: computational modeling and experimental validation","volume":"132","author":"Cuy\u00e0s","year":"2019","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.phymed.2024.155493_bib0027","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1186\/s13046-017-0584-3","article-title":"(S)-crizotinib induces apoptosis in human non-small cell lung cancer cells by activating ROS independent of MTH1","volume":"36","author":"Dai","year":"2017","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.phymed.2024.155493_bib0028","doi-asserted-by":"crossref","first-page":"2881","DOI":"10.1007\/s00432-022-04026-w","article-title":"Brain infiltration of breast cancer stem cells is facilitated by paracrine signaling by inhibitor of differentiation 3 to nuclear respiratory factor 1","volume":"148","author":"Das","year":"2022","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"10.1016\/j.phymed.2024.155493_bib0029","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1007\/s12031-014-0401-9","article-title":"Microvascular lesions by estrogen-induced ID3: its implications in cerebral and cardiorenal vascular disease","volume":"55","author":"Das","year":"2015","journal-title":"J. Mol. Neurosci."},{"key":"10.1016\/j.phymed.2024.155493_bib0030","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0104159","article-title":"PCB153-induced overexpression of ID3 contributes to the development of microvascular lesions","volume":"9","author":"Das","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1016\/j.phymed.2024.155493_bib0031","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.mvr.2015.01.006","article-title":"ID3 contributes to the acquisition of molecular stem cell-like signature in microvascular endothelial cells: its implication for understanding microvascular diseases","volume":"98","author":"Das","year":"2015","journal-title":"Microvasc. Res."},{"key":"10.1016\/j.phymed.2024.155493_bib0032","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1182\/blood-2006-07-034124","article-title":"Identification of BMP9 and BMP10 as functional activators of the orphan activin receptor-like kinase 1 (ALK1) in endothelial cells","volume":"109","author":"David","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.phymed.2024.155493_bib0033","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1042\/BST20160093","article-title":"Targeting tumour vasculature by inhibiting activin receptor-like kinase (ALK)1 function","volume":"44","author":"de Vinuesa","year":"2016","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.phymed.2024.155493_bib0034","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1007\/s10555-010-9237-0","article-title":"Antimetastatic efficacy of silibinin: molecular mechanisms and therapeutic potential against cancer","volume":"29","author":"Deep","year":"2010","journal-title":"Cancer Metastasis Rev."},{"key":"10.1016\/j.phymed.2024.155493_bib0035","doi-asserted-by":"crossref","first-page":"486","DOI":"10.2174\/15680096113139990041","article-title":"Targeting tumor microenvironment with silibinin: promise and potential for a translational cancer chemopreventive strategy","volume":"13","author":"Deep","year":"2013","journal-title":"Curr. Cancer Drug Targets"},{"key":"10.1016\/j.phymed.2024.155493_bib0036","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1002\/mc.22537","article-title":"Silibinin inhibits hypoxia-induced HIF-1\u03b1-mediated signaling, angiogenesis and lipogenesis in prostate cancer cells: in vitro evidence and in vivo functional imaging and metabolomics","volume":"56","author":"Deep","year":"2017","journal-title":"Mol. Carcinog."},{"key":"10.1016\/j.phymed.2024.155493_bib0037","doi-asserted-by":"crossref","first-page":"525","DOI":"10.3390\/v12050525","article-title":"Potential Drugs targeting early innate immune evasion of sars-coronavirus 2 via 2\u2032-O-methylation of viral RNA","volume":"12","author":"Encinar","year":"2020","journal-title":"Viruses"},{"key":"10.1016\/j.phymed.2024.155493_bib0038","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.atherosclerosis.2007.12.048","article-title":"Estrogen-induced redox sensitive Id3 signaling controls the growth of vascular cells","volume":"198","author":"Felty","year":"2008","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.phymed.2024.155493_bib0039","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1126\/science.1150224","article-title":"Endothelial progenitor cells control the angiogenic switch in mouse lung metastasis","volume":"319","author":"Gao","year":"2008","journal-title":"Science"},{"key":"10.1016\/j.phymed.2024.155493_bib0040","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/onc.2008.398","article-title":"Silibinin inhibits hypoxia-inducible factor-1alpha and mTOR\/p70S6K\/4E-BP1 signalling pathway in human cervical and hepatoma cancer cells: implications for anticancer therapy","volume":"28","author":"Garc\u00eda-Maceira","year":"2009","journal-title":"Oncogene"},{"key":"10.1016\/j.phymed.2024.155493_bib0041","doi-asserted-by":"crossref","first-page":"e219","DOI":"10.1371\/journal.pgen.0030219","article-title":"A mechanism misregulating p27 in tumors discovered in a functional genomic screen","volume":"3","author":"Garrett-Engele","year":"2007","journal-title":"PLoS Genet."},{"key":"10.1016\/j.phymed.2024.155493_bib0042","doi-asserted-by":"crossref","first-page":"6081","DOI":"10.1016\/j.cell.2021.11.016","article-title":"An NK-like CAR T cell transition in CAR T cell dysfunction","volume":"184","author":"Good","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.phymed.2024.155493_bib0043","article-title":"Crizotinib and sunitinib induce hepatotoxicity and mitochondrial apoptosis in L02 Cells via ROS and Nrf2 signaling pathway","volume":"12","author":"Guo","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.phymed.2024.155493_bib0044","doi-asserted-by":"crossref","first-page":"19506","DOI":"10.1073\/pnas.0709185104","article-title":"ID genes mediate tumor reinitiation during breast cancer lung metastasis","volume":"104","author":"Gupta","year":"2007","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.phymed.2024.155493_bib0045","doi-asserted-by":"crossref","first-page":"13057","DOI":"10.1073\/pnas.1603668113","article-title":"BMP-SMAD-ID promotes reprogramming to pluripotency by inhibiting p16\/INK4A-dependent senescence","volume":"113","author":"Hayashi","year":"2016","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.phymed.2024.155493_bib0046","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.3000557","article-title":"BMPR2 acts as a gatekeeper to protect endothelial cells from increased TGF\u03b2 responses and altered cell mechanics","volume":"17","author":"Hiepen","year":"2019","journal-title":"PLoS Biol."},{"key":"10.1016\/j.phymed.2024.155493_bib0047","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.3390\/cells9091965","article-title":"It takes two to tango: endothelial TGF\u03b2\/BMP signaling crosstalk with mechanobiology","volume":"9","author":"Hiepen","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.phymed.2024.155493_bib0048","doi-asserted-by":"crossref","first-page":"2944","DOI":"10.1158\/1078-0432.CCR-05-2724","article-title":"Pilot study of oral silibinin, a putative chemopreventive agent, in colorectal cancer patients: silibinin levels in plasma, colorectum, and liver and their pharmacodynamic consequences","volume":"12","author":"Hoh","year":"2006","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.phymed.2024.155493_bib125","doi-asserted-by":"crossref","first-page":"19838","DOI":"10.1074\/jbc.274.28.19838","article-title":"Id genes are direct targets of bone morphogenetic protein induction in embryonic stem cells","volume":"274","author":"Hollnagel","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.phymed.2024.155493_bib0049","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1002\/hep.30404","article-title":"ID3 Promotes Stem Cell Features and Predicts Chemotherapeutic Response of Intrahepatic Cholangiocarcinoma","volume":"69","author":"Huang","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/j.phymed.2024.155493_bib0050","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/j.molmed.2006.10.007","article-title":"ID proteins as targets in cancer and tools in neurobiology","volume":"12","author":"Iavarone","year":"2006","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.phymed.2024.155493_bib0051","series-title":"Cancer Res.","first-page":"1128","article-title":"Exosomal ID3 is pro-metastatic through guiding NRF1-induced breast cancer stem cells across the blood-brain-barrier","volume":"78","author":"Das","year":"2018"},{"key":"10.1016\/j.phymed.2024.155493_bib0052","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.bbrc.2009.09.068","article-title":"Silibinin inhibits expression of HIF-1alpha through suppression of protein translation in prostate cancer cells","volume":"390","author":"Jung","year":"2009","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.phymed.2024.155493_bib0053","first-page":"3887","article-title":"Inhibitor of DNA binding proteins: implications in human cancer progression and metastasis","volume":"10","author":"Ke","year":"2018","journal-title":"Am. J. Transl. Res."},{"key":"10.1016\/j.phymed.2024.155493_bib0054","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/s10456-014-9457-y","article-title":"A small molecule targeting ALK1 prevents Notch cooperativity and inhibits functional angiogenesis","volume":"18","author":"Kerr","year":"2015","journal-title":"Angiogenesis"},{"key":"10.1016\/j.phymed.2024.155493_bib0055","first-page":"226","article-title":"Bioavailability and activity of phytosome complexes from botanical polyphenols: the silymarin, curcumin, green tea, and grape seed extracts","volume":"14","author":"Kidd","year":"2009","journal-title":"Altern. Med. Rev."},{"key":"10.1016\/j.phymed.2024.155493_bib0056","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/j.molonc.2013.08.001","article-title":"Epithelial-mesenchymal transition leads to crizotinib resistance in H2228 lung cancer cells with EML4-ALK translocation","volume":"7","author":"Kim","year":"2013","journal-title":"Mol. Oncol."},{"key":"10.1016\/j.phymed.2024.155493_bib0057","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.cels.2022.03.002","article-title":"The context-dependent, combinatorial logic of BMP signaling","volume":"13","author":"Klumpe","year":"2022","journal-title":"Cell Syst"},{"key":"10.1016\/j.phymed.2024.155493_bib0058","doi-asserted-by":"crossref","first-page":"4241","DOI":"10.1128\/MCB.24.10.4241-4254.2004","article-title":"Id2 and Id3 define the potency of cell proliferation and differentiation responses to transforming growth factor beta and bone morphogenetic protein","volume":"24","author":"Kowanetz","year":"2004","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.phymed.2024.155493_bib0059","doi-asserted-by":"crossref","first-page":"7885","DOI":"10.3390\/ijms22157885","article-title":"Chirality matters: biological activity of optically pure silybin and its congeners","volume":"22","author":"K\u0159en","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.phymed.2024.155493_bib0060","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1186\/1476-4598-12-129","article-title":"Small molecule antagonist of the bone morphogenetic protein type I receptors suppresses growth and expression of Id1 and Id3 in lung cancer cells expressing Oct4 or nestin","volume":"12","author":"Langenfeld","year":"2013","journal-title":"Mol. Cancer."},{"key":"10.1016\/j.phymed.2024.155493_bib0061","doi-asserted-by":"crossref","first-page":"e61256","DOI":"10.1371\/journal.pone.0061256","article-title":"Bone morphogenetic protein type I receptor antagonists decrease growth and induce cell death of lung cancer cell lines","volume":"8","author":"Langenfeld","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.phymed.2024.155493_bib0062","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1016\/j.athoracsur.2005.03.094","article-title":"Expression of bone morphogenetic proteins in human lung carcinomas","volume":"80","author":"Langenfeld","year":"2005","journal-title":"Ann. Thorac. Surg."},{"key":"10.1016\/j.phymed.2024.155493_bib0063","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1093\/carcin\/bgg100","article-title":"The mature bone morphogenetic protein-2 is aberrantly expressed in non-small cell lung carcinomas and stimulates tumor growth of A549 cells","volume":"24","author":"Langenfeld","year":"2003","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.phymed.2024.155493_bib0064","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1038\/sj.onc.1209110","article-title":"Bone morphogenetic protein 2 stimulation of tumor growth involves the activation of Smad-1\/5","volume":"25","author":"Langenfeld","year":"2006","journal-title":"Oncogene"},{"key":"10.1016\/j.phymed.2024.155493_bib0065","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/nrc3638","article-title":"The ID proteins: master regulators of cancer stem cells and tumour aggressiveness","volume":"14","author":"Lasorella","year":"2014","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.phymed.2024.155493_bib0066","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1038\/sj.bjc.6601684","article-title":"Overexpression of Id-1 is significantly associated with tumour angiogenesis in human pancreas cancers","volume":"90","author":"Lee","year":"2004","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.phymed.2024.155493_bib0067","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1016\/j.bbagrm.2013.08.002","article-title":"Serum regulation of Id1 expression by a BMP pathway and BMP responsive element","volume":"1829","author":"Lewis","year":"2013","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.phymed.2024.155493_bib0068","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1158\/1535-7163.MCT-08-1152","article-title":"Silibinin inhibits translation initiation: implications for anticancer therapy","volume":"8","author":"Lin","year":"2009","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.phymed.2024.155493_bib0069","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/B978-0-12-405943-6.00005-1","article-title":"Id proteins: small molecules, mighty regulators","volume":"110","author":"Ling","year":"2014","journal-title":"Curr. Top. Dev. Biol."},{"key":"10.1016\/j.phymed.2024.155493_bib0070","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1038\/44334","article-title":"Id1 and Id3 are required for neurogenesis, angiogenesis and vascularization of tumour xenografts","volume":"401","author":"Lyden","year":"1999","journal-title":"Nature"},{"key":"10.1016\/j.phymed.2024.155493_bib0071","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/labinvest.2008.112","article-title":"Endoglin and activin receptor-like-kinase 1 are co-expressed in the distal vessels of the lung: implications for two familial vascular dysplasias, HHT and PAH","volume":"89","author":"Mahmoud","year":"2009","journal-title":"Lab. Invest."},{"key":"10.1016\/j.phymed.2024.155493_bib0072","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1158\/1078-0432.CCR-15-0876","article-title":"A patient-derived, pan-cancer emt signature identifies global molecular alterations and immune target enrichment following epithelial-to-mesenchymal transition","volume":"22","author":"Mak","year":"2016","journal-title":"Clin. Cancer Res."},{"issue":"Suppl 1","key":"10.1016\/j.phymed.2024.155493_bib0073","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1080\/01635581.2013.785004","article-title":"Chemopreventive and anti-cancer efficacy of silibinin against growth and progression of lung cancer","volume":"65","author":"Mateen","year":"2013","journal-title":"Nutr. Cancer"},{"key":"10.1016\/j.phymed.2024.155493_bib0074","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1038\/sj.bjc.6604722","article-title":"Expression of the inhibitor of DNA-binding (ID)-1 protein as an angiogenic mediator in tumour advancement of uterine cervical cancers","volume":"99","author":"Maw","year":"2008","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.phymed.2024.155493_bib0075","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1038\/sj.bjc.6605897","article-title":"Inhibition of Id proteins by a peptide aptamer induces cell-cycle arrest and apoptosis in ovarian cancer cells","volume":"103","author":"Mern","year":"2010","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.phymed.2024.155493_bib0076","doi-asserted-by":"crossref","first-page":"8421","DOI":"10.1021\/acsomega.9b00224","article-title":"Combination of Epigallocatechin-3-gallate and silibinin: a novel approach for targeting both tumor and endothelial cells","volume":"4","author":"Mirzaaghaei","year":"2019","journal-title":"ACS Omega"},{"key":"10.1016\/j.phymed.2024.155493_bib0077","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.7150\/jca.15690","article-title":"Curcumin sensitizes silymarin to exert synergistic anticancer activity in colon cancer cells","volume":"7","author":"Montgomery","year":"2016","journal-title":"J. Cancer."},{"key":"10.1016\/j.phymed.2024.155493_bib0078","doi-asserted-by":"crossref","first-page":"2423","DOI":"10.1161\/01.CIR.0000016047.19488.91","article-title":"Identification of a novel redox-sensitive gene, Id3, which mediates angiotensin II-induced cell growth","volume":"105","author":"Mueller","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.phymed.2024.155493_bib0079","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1038\/mt.2014.83","article-title":"ID proteins regulate diverse aspects of cancer progression and provide novel therapeutic opportunities","volume":"22","author":"Nair","year":"2014","journal-title":"Mol. Ther."},{"key":"10.1016\/j.phymed.2024.155493_bib0080","doi-asserted-by":"crossref","first-page":"3672","DOI":"10.1038\/s41388-018-0156-9","article-title":"Novel bone morphogenetic protein receptor inhibitor JL5 suppresses tumor cell survival signaling and induces regression of human lung cancer","volume":"37","author":"Newman","year":"2018","journal-title":"Oncogene"},{"key":"10.1016\/j.phymed.2024.155493_bib0081","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.3390\/cells8121579","article-title":"Specification of BMP Signaling","volume":"8","author":"Nickel","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.phymed.2024.155493_bib0082","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1038\/ncb2490","article-title":"Id proteins synchronize stemness and anchorage to the niche of neural stem cells","volume":"14","author":"Niola","year":"2012","journal-title":"Nat. Cell. Biol."},{"key":"10.1016\/j.phymed.2024.155493_bib0083","doi-asserted-by":"crossref","first-page":"709","DOI":"10.4049\/jimmunol.1300272","article-title":"TGF-\u03b21, but not bone morphogenetic proteins, activates Smad1\/5 pathway in primary human macrophages and induces expression of proatherogenic genes","volume":"194","author":"Nurgazieva","year":"2015","journal-title":"J. Immunol."},{"key":"10.1016\/j.phymed.2024.155493_bib0084","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/j.ccr.2012.04.036","article-title":"ID1 and ID3 regulate the self-renewal capacity of human colon cancer-initiating cells through p21","volume":"21","author":"O'Brien","year":"2012","journal-title":"Cancer Cell"},{"key":"10.1016\/j.phymed.2024.155493_bib0085","doi-asserted-by":"crossref","first-page":"2626","DOI":"10.1073\/pnas.97.6.2626","article-title":"Activin receptor-like kinase 1 modulates transforming growth factor-beta 1 signaling in the regulation of angiogenesis","volume":"97","author":"Oh","year":"2000","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.phymed.2024.155493_bib0086","doi-asserted-by":"crossref","DOI":"10.1016\/j.mvr.2022.104337","article-title":"Molecular basis of the association between transcription regulators nuclear respiratory factor 1 and inhibitor of DNA binding protein 3 and the development of microvascular lesions","volume":"141","author":"Perez","year":"2022","journal-title":"Microvasc. Res."},{"key":"10.1016\/j.phymed.2024.155493_bib0087","article-title":"Inhibitor of DNA binding protein 3 (ID3) and nuclear respiratory factor 1 (NRF1) mediated transcriptional gene signatures are associated with the severity of cerebral amyloid angiopathy","author":"Perez","year":"2023","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.phymed.2024.155493_bib0088","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1038\/nrc1673","article-title":"Id family of helix-loop-helix proteins in cancer","volume":"5","author":"Perk","year":"2005","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.phymed.2024.155493_bib0089","doi-asserted-by":"crossref","first-page":"2351","DOI":"10.1182\/blood-2007-01-069914","article-title":"Id1, but not Id3, directs long-term repopulating hematopoietic stem-cell maintenance","volume":"110","author":"Perry","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.phymed.2024.155493_bib0090","doi-asserted-by":"crossref","first-page":"4155","DOI":"10.1158\/1078-0432.CCR-10-3381","article-title":"Inhibitor of differentiation-1 as a novel prognostic factor in NSCLC patients with adenocarcinoma histology and its potential contribution to therapy resistance","volume":"17","author":"Ponz-Sarvis\u00e9","year":"2011","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.phymed.2024.155493_bib0091","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.3389\/fimmu.2019.01314","article-title":"The Potential of astrocytes as immune modulators in brain tumors","volume":"10","author":"Priego","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.phymed.2024.155493_bib0092","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1038\/s41591-018-0044-4","article-title":"STAT3 labels a subpopulation of reactive astrocytes required for brain metastasis","volume":"24","author":"Priego","year":"2018","journal-title":"Nat. Med."},{"key":"10.1016\/j.phymed.2024.155493_bib0093","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1038\/ng.2469","article-title":"Recurrent mutation of the ID3 gene in Burkitt lymphoma identified by integrated genome, exome and transcriptome sequencing","volume":"44","author":"Richter","year":"2012","journal-title":"Nat. Genet."},{"key":"10.1016\/j.phymed.2024.155493_bib0094","doi-asserted-by":"crossref","first-page":"20729","DOI":"10.1021\/acsomega.1c02983","article-title":"Recent advances in ALK2 inhibitors","volume":"6","author":"Rooney","year":"2021","journal-title":"ACS Omega"},{"key":"10.1016\/j.phymed.2024.155493_bib0095","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s12964-016-0161-y","article-title":"The Id-protein family in developmental and cancer-associated pathways","volume":"15","author":"Roschger","year":"2017","journal-title":"Cell. Commun. Signal."},{"key":"10.1016\/j.phymed.2024.155493_bib0096","doi-asserted-by":"crossref","first-page":"110166","DOI":"10.18632\/oncotarget.22698","article-title":"New role of ID3 in melanoma adaptive drug-resistance","volume":"8","author":"Sachindra","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.phymed.2024.155493_bib0097","doi-asserted-by":"crossref","DOI":"10.1016\/j.bone.2020.115472","article-title":"Bone morphogenetic protein receptors: structure, function and targeting by selective small molecule kinase inhibitors","volume":"138","author":"Sanchez-Duffhues","year":"2020","journal-title":"Bone"},{"key":"10.1016\/j.phymed.2024.155493_bib0098","doi-asserted-by":"crossref","first-page":"e62721","DOI":"10.1371\/journal.pone.0062721","article-title":"A new class of small molecule inhibitor of BMP signaling","volume":"8","author":"Sanvitale","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.phymed.2024.155493_bib0099","article-title":"Curcumin, but not its degradation products, in combination with silibinin is primarily responsible for the inhibition of colon cancer cell proliferation","author":"Sayyed","year":"2022","journal-title":"MicroPubl. Biol."},{"key":"10.1016\/j.phymed.2024.155493_bib0100","first-page":"779","article-title":"Level of Id-1 protein expression correlates with poor differentiation, enhanced malignant potential, and more aggressive clinical behavior of epithelial ovarian tumors","volume":"9","author":"Schindl","year":"2003","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.phymed.2024.155493_bib0101","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1158\/0008-5472.CAN-14-2535","article-title":"Molecular portraits of epithelial, mesenchymal, and hybrid States in lung adenocarcinoma and their relevance to survival","volume":"75","author":"Schliekelman","year":"2015","journal-title":"Cancer Res."},{"key":"10.1016\/j.phymed.2024.155493_bib0102","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1002\/ijc.11009","article-title":"Overexpression of Id-1 is associated with poor clinical outcome in node negative breast cancer","volume":"104","author":"Schoppmann","year":"2003","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.phymed.2024.155493_bib0103","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1021\/acschemneuro.7b00110","article-title":"Inhibition of A\u03b2 amyloid growth and toxicity by silybins: the crucial role of stereochemistry","volume":"8","author":"Sciacca","year":"2017","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.phymed.2024.155493_bib0104","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1002\/cam4.19","article-title":"Id1 and Id3 expression is associated with increasing grade of prostate cancer: id3 preferentially regulates CDKN1B","volume":"1","author":"Sharma","year":"2012","journal-title":"Cancer Med."},{"key":"10.1016\/j.phymed.2024.155493_bib0105","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.gene.2008.02.015","article-title":"Autocrine BMP4 signalling regulates ID3 proto-oncogene expression in human ovarian cancer cells","volume":"414","author":"Shepherd","year":"2008","journal-title":"Gene"},{"key":"10.1016\/j.phymed.2024.155493_bib0106","doi-asserted-by":"crossref","DOI":"10.3389\/fncel.2022.922181","article-title":"Blood-brain barrier alterations and edema formation in different brain mass lesions","volume":"16","author":"Solar","year":"2022","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.phymed.2024.155493_bib0107","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1016\/j.celrep.2013.11.014","article-title":"TGF-\u03b2-Id1 signaling opposes Twist1 and promotes metastatic colonization via a mesenchymal-to-epithelial transition","volume":"5","author":"Stankic","year":"2013","journal-title":"Cell Rep."},{"key":"10.1016\/j.phymed.2024.155493_bib0108","doi-asserted-by":"crossref","first-page":"552","DOI":"10.3389\/fcell.2020.00552","article-title":"Id proteins promote a cancer stem cell phenotype in mouse models of triple negative breast cancer via negative regulation of robo1","volume":"8","author":"Teo","year":"2020","journal-title":"Front. Cell. Dev. Biol."},{"key":"10.1016\/j.phymed.2024.155493_bib0109","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.lungcan.2019.10.012","article-title":"Gene signatures of tumor inflammation and epithelial-to-mesenchymal transition (EMT) predict responses to immune checkpoint blockade in lung cancer with high accuracy","volume":"139","author":"Thompson","year":"2020","journal-title":"Lung Cancer"},{"key":"10.1016\/j.phymed.2024.155493_bib0110","doi-asserted-by":"crossref","first-page":"9455","DOI":"10.1158\/0008-5472.CAN-05-1058","article-title":"Epithelial to mesenchymal transition is a determinant of sensitivity of non-small-cell lung carcinoma cell lines and xenografts to epidermal growth factor receptor inhibition","volume":"65","author":"Thomson","year":"2005","journal-title":"Cancer Res."},{"key":"10.1016\/j.phymed.2024.155493_bib0111","doi-asserted-by":"crossref","first-page":"3923","DOI":"10.1111\/jog.15003","article-title":"Crizotinib-induced anti-cancer activity in human cervical carcinoma cells via ROS-dependent mitochondrial depolarization and induction of apoptotic pathway","volume":"47","author":"Varma","year":"2021","journal-title":"J. Obstet. Gynaecol. Res."},{"key":"10.1016\/j.phymed.2024.155493_bib0112","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1038\/srep02560","article-title":"IGF-1R\/epithelial-to-mesenchymal transition (EMT) crosstalk suppresses the erlotinib-sensitizing effect of EGFR exon 19 deletion mutations","volume":"3","author":"Vazquez-Martin","year":"2013","journal-title":"Sci. Rep."},{"key":"10.1016\/j.phymed.2024.155493_bib0113","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.fct.2018.04.028","article-title":"Silibinin is a direct inhibitor of STAT3","volume":"116","author":"Verdura","year":"2018","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.phymed.2024.155493_bib0114","doi-asserted-by":"crossref","first-page":"559","DOI":"10.3390\/ph14060559","article-title":"Lung cancer management with silibinin: a historical and translational perspective","volume":"14","author":"Verdura","year":"2021","journal-title":"Pharmaceuticals (Basel)"},{"key":"10.1016\/j.phymed.2024.155493_bib0115","doi-asserted-by":"crossref","first-page":"6101","DOI":"10.3390\/cancers14246101","article-title":"Silibinin overcomes EMT-driven lung cancer resistance to new-generation ALK inhibitors","volume":"14","author":"Verdura","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.phymed.2024.155493_bib0116","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.neulet.2012.08.078","article-title":"Protection by silibinin against experimental ischemic stroke: up-regulated pAkt, pmTOR, HIF-1\u03b1 and Bcl-2, down-regulated Bax, NF-\u03baB expression","volume":"529","author":"Wang","year":"2012","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.phymed.2024.155493_bib0117","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.devcel.2015.10.019","article-title":"E proteins and ID proteins: helix-loop-helix partners in development and disease","volume":"35","author":"Wang","year":"2015","journal-title":"Dev. Cell."},{"key":"10.1016\/j.phymed.2024.155493_bib0118","doi-asserted-by":"crossref","first-page":"298","DOI":"10.3389\/fonc.2017.00298","article-title":"Reactive astrocytes in brain metastasis","volume":"7","author":"Wasilewski","year":"2017","journal-title":"Front. Oncol."},{"key":"10.1016\/j.phymed.2024.155493_bib0119","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1096\/fj.04-3458fje","article-title":"Blood-brain barrier-specific properties of a human adult brain endothelial cell line","volume":"19","author":"Weksler","year":"2005","journal-title":"FASEB J."},{"key":"10.1016\/j.phymed.2024.155493_bib0120","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1038\/s41523-021-00266-0","article-title":"Anti-tumor effects of an ID antagonist with no observed acquired resistance","volume":"7","author":"Wojnarowicz","year":"2021","journal-title":"NPJ Breast Cancer"},{"key":"10.1016\/j.phymed.2024.155493_bib0121","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.celrep.2019.08.073","article-title":"A small-molecule pan-id antagonist inhibits pathologic ocular neovascularization","volume":"29","author":"Wojnarowicz","year":"2019","journal-title":"Cell Rep."},{"key":"10.1016\/j.phymed.2024.155493_bib0122","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.lungcan.2013.09.019","article-title":"Dual ALK and EGFR inhibition targets a mechanism of acquired resistance to the tyrosine kinase inhibitor crizotinib in ALK rearranged lung cancer","volume":"83","author":"Yamaguchi","year":"2014","journal-title":"Lung Cancer"},{"key":"10.1016\/j.phymed.2024.155493_bib0123","doi-asserted-by":"crossref","DOI":"10.1016\/j.taap.2019.114768","article-title":"ROS-dependent DNA damage contributes to crizotinib-induced hepatotoxicity via the apoptotic pathway","volume":"383","author":"Yan","year":"2019","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.phymed.2024.155493_bib0124","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1093\/cvr\/cvu215","article-title":"Id proteins in the vasculature: from molecular biology to cardiopulmonary medicine","volume":"104","author":"Yang","year":"2014","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.phymed.2024.155493_bib126","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0092-8674(03)00847-X","article-title":"BMP induction of Id proteins suppresses differentiation and sustains embryonic stem cell self-renewal in collaboration with STAT3","volume":"115","author":"Ying","year":"2003","journal-title":"Cell"}],"container-title":["Phytomedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0944711324001570?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0944711324001570?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T23:46:48Z","timestamp":1777592808000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0944711324001570"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":126,"alternative-id":["S0944711324001570"],"URL":"https:\/\/doi.org\/10.1016\/j.phymed.2024.155493","relation":{},"ISSN":["0944-7113"],"issn-type":[{"value":"0944-7113","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Silibinin is a suppressor of the metastasis-promoting transcription factor ID3","name":"articletitle","label":"Article Title"},{"value":"Phytomedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phymed.2024.155493","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier GmbH.","name":"copyright","label":"Copyright"}],"article-number":"155493"}}